$ALMU
Aeluma, Inc. Stock $almu

$almu Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000121390024082694 Filed on September 27, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$480.7K		$918.6K
YoY Change	1383.75%		375.1%
Cost Of Revenue	$314.6K		$619.2K
YoY Change	1977.91%		466.07%
Gross Profit	$166.2K		$299.3K
YoY Change	862.63%		256.55%
Gross Profit Margin	34.56%		32.58%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$401.1K		$2.507M
YoY Change	-51.96%		15.23%
% of Gross Profit	241.38%		837.44%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$401.1K		$2.507M
YoY Change	-51.96%		15.23%
Operating Profit	-$731.4K		-$4.563M
YoY Change	-50.67%		-17.18%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.761K		$1.013K
YoY Change	338.06%		-99.22%
Pretax Income	-$729.6K		-$4.562M
YoY Change	-50.78%		-15.19%
Income Tax
% Of Pretax Income
Net Earnings	-$729.6K		-$4.562M
YoY Change	-50.78%		-15.19%
Net Earnings / Revenue	-151.77%		-496.68%
Basic Earnings Per Share	-$0.06		-$0.37
Diluted Earnings Per Share	-$0.06		-$0.37
COMMON SHARES
Basic Shares Outstanding	12.18M shares	12.18M shares	12.30M shares
Diluted Shares Outstanding	12.18M shares		12.30M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$3.503M	$1.291M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$322.2K	$60.00K
Other Receivables
Total Short-Term Assets	$4.027M	$1.393M
YoY Change	0.17%	-73.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.372M	$1.470M
YoY Change	-1.59%	0.94%
Goodwill
YoY Change
Intangibles	$6.083K	$6.833K
YoY Change	-33.03%	-30.51%
Long-Term Investments
YoY Change
Other Assets	$13.01K	$13.01K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$2.322M	$2.451M
YoY Change	-6.44%	33.95%
TOTAL ASSETS
Total Short-Term Assets	$4.027M	$1.393M
Total Long-Term Assets	$2.322M	$2.451M
Total Assets	$6.349M	$3.844M
YoY Change	-2.35%	-46.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$238.1K	$317.2K
YoY Change	-25.57%	-31.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.631M	$626.7K
YoY Change	339.47%	-17.23%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.631M	$626.7K
Total Long-Term Liabilities
Total Liabilities	$4.635M	$1.568M
YoY Change	183.12%	48.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.35M	-$13.62M
YoY Change	36.13%	50.34%
Common Stock	$1.218K	$1.218K
YoY Change	0.08%	-4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.714M	$2.276M
YoY Change
Total Liabilities & Shareholders Equity	$6.349M	$3.844M
YoY Change	-2.35%	-46.34%

Cashflow Statement

Concept	2024 Q3	2024
OPERATING ACTIVITIES
Net Income	-$729.6K	-$4.562M
YoY Change	-50.78%	-15.19%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$931.9K	-$3.455M
YoY Change	-28.5%	-5.04%
INVESTING ACTIVITIES
Capital Expenditures	$1.637K	$321.8K
YoY Change	-76.94%	-52.15%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.637K	-$321.8K
YoY Change	-76.94%	-52.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$4.001K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.145M	-$4.001K
YoY Change	-78705.35%	-100.07%
NET CHANGE
Cash From Operating Activities	-$931.9K	-$3.455M
Cash From Investing Activities	-$1.637K	-$321.8K
Cash From Financing Activities	$3.145M	-$4.001K
Net Change In Cash	$2.211M	-$3.781M
YoY Change	-268.24%	-384.05%
FREE CASH FLOW
Cash From Operating Activities	-$931.9K	-$3.455M
Capital Expenditures	$1.637K	$321.8K
Free Cash Flow	-$933.6K	-$3.777M
YoY Change	-28.76%	-12.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Security Exchange Name SecurityExchangeName	NONE
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11379480	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12298355	shares
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	309248	usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-56218
CY2024	dei	Entity Registrant Name EntityRegistrantName	AELUMA, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2807351
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	27 Castilian Drive
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Goleta
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93117
CY2024	dei	City Area Code CityAreaCode	(805)
CY2024	dei	Local Phone Number LocalPhoneNumber	351-2707
CY2024	dei	Security12b Title Security12bTitle	None
CY2024	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	29294872	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12178424	shares
CY2024	dei	Auditor Name AuditorName	Rose, Snyder & Jacobs LLP
CY2024	dei	Auditor Location AuditorLocation	Encino, California
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1291072	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5071690	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60004	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	189239	usd
CY2024Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	20133	usd
CY2023Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	53034	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21637	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19943	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	1392846	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	5333906	usd
CY2024Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1531494	usd
CY2023Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1209656	usd
CY2024Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	546864	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	546864	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	608630	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	300445	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1469728	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1456075	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6833	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9833	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	961626	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	351013	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13014	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13014	usd
CY2024Q2	us-gaap	Assets Assets	3844047	usd
CY2023Q2	us-gaap	Assets Assets	7163841	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	317237	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	461797	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	180706	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	133092	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	128743	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	162210	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	626686	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	757099	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	941200	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	296452	usd
CY2024Q2	us-gaap	Liabilities Liabilities	1567886	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1053551	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12178424	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12178424	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12817500	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12817500	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1218	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1282	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15899304	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15171074	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13624361	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9062066	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2276161	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6110290	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3844047	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7163841	usd
CY2024	us-gaap	Revenues Revenues	918554	usd
CY2023	us-gaap	Revenues Revenues	193339	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	619249	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	109395	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2506507	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2531624	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2356106	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3062005	usd
CY2024	us-gaap	Costs And Expenses CostsAndExpenses	5481862	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	5703024	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-4563308	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-5509685	usd
CY2023	almu	Sub Lease Rental Income And Other Income SubLeaseRentalIncomeAndOtherIncome	128913	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	1013	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1190	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1013	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	130103	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4562295	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5379582	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4562295	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5379582	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12298355	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11379480	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5099943	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	411015	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5641485	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	448444	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5379582	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6110290	usd
CY2024	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4001	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	732167	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4562295	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2276161	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4562295	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5379582	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	258000	usd
CY2024	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	32901	usd
CY2023	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	662464	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	732167	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	448444	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	311185	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	206458	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-129235	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	189239	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1694	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7719	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-144560	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	347697	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	48282	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	67	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3454779	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3637972	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	321838	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	590043	usd
CY2023	almu	Payment For Leasehold Improvements PaymentForLeaseholdImprovements	82502	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-321838	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-672545	usd
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4001	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5641485	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4001	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5641485	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3780618	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1330968	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5071690	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3740722	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1291072	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5071690	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1 – The Company</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aeluma, Inc., headquartered in Goleta, California, is engaged in the research and development of infrared (IR) optical sensors to disrupt the market for IR sensors, and using its proprietary technology aims to produce a much higher performance alternative to today’s low-cost sensors at much lower prices than would otherwise be possible. The focus of Aeluma, Inc. (“the Company”) will be the image sensor market. Initial efforts hope to penetrate the 3D imaging and sensing (mobile and consumer, defense and aerospace, industrial, medical, auto) and LiDAR (robotic vehicles, advanced driver assistance systems vehicles (ADAS), topography, wind, industrial) markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Going Concern</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company incurred a net loss of $4,562,295 and $5,379,582 for the years ended June 30, 2024 and 2023, respectively, and has accumulated deficit of $13,624,361 at June 30, 2024. In addition, the Company is in the research and development stage and has generated limited revenue to date. In order to support its operations, the Company will require additional infusions of cash from the sale of equity instruments or the issuance of debt instruments, or the commencement of profitable revenue generating activities. If adequate funds are not available or are not available on acceptable terms, the Company’s ability to fund its operations, develop or enhance its sensors in the future or respond to competitive pressures would be significantly limited. Such limitations could require the Company to curtail, suspend or discontinue parts of its business plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These conditions raise doubt about the Company’s ability to continue as a going concern. The accompanying financial statements have been prepared in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), which contemplate continuation of the Company as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.</p>
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4562295	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5379582	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13624361	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates and Assumptions</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. </p>
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Reclassification of Prior Year Presentation</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentration of Risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company’s accounts are insured by the FDIC but at times may exceed federally insured limits.</p>
CY2024Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y
CY2024	us-gaap	Revenues Revenues	918554	usd
CY2024	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	almu	Placement Agent Fees And Expenses PlacementAgentFeesAndExpenses	124385	usd
CY2023Q1	almu	Placement Agent Fees And Expenses PlacementAgentFeesAndExpenses	28640	usd
CY2023Q1	almu	Placement Agent Fees And Expenses PlacementAgentFeesAndExpenses	117830	usd
CY2023Q2	almu	Placement Agent Fees And Expenses PlacementAgentFeesAndExpenses	140160	usd
CY2024	almu	Placement Agent Fees And Expenses PlacementAgentFeesAndExpenses	411015	usd
CY2020Q4	almu	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Shares Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedSharesPercentage	0.20	pure
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	324784	shares
CY2024Q2	almu	Agreement Percentage AgreementPercentage	0.08	pure
CY2024	almu	Covered Shares CoveredShares	11010002	shares
CY2024	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1372435	usd
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	300000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	20133	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2024	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	2.99
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.52
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.45
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	732167	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	448444	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	857026	usd
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y1M6D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1034000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.31
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	120821	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.01
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	201000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.08
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	953821	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.45
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	550116	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.36
CY2024	almu	Excess Of Fair Value Price Per Share ExcessOfFairValuePricePerShare	3.59
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	817750	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	471250	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.68
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	255000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1034000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.31
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	360060	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.05
CY2023	almu	Excess Of Fair Value Price Per Share ExcessOfFairValuePricePerShare	2.9
CY2021Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	781813	usd
CY2024	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	767553	usd
CY2023Q3	us-gaap	Net Investment In Lease Change In Present Value Interest Income NetInvestmentInLeaseChangeInPresentValueInterestIncome	1189606	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	169224	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	173454	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	177791	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	182235	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	186791	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	337732	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1227227	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	157284	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1069943	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	128743	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	941200	usd
CY2024Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P6Y9M18D
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.04	pure
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	167097	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	129437	usd
CY2024	us-gaap	Variable Lease Cost VariableLeaseCost	240431	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	264280	usd
CY2021Q2	us-gaap	Sublease Income SubleaseIncome	13013	usd
CY2021Q2	us-gaap	Sublease Income SubleaseIncome	8400	usd
CY2022Q2	us-gaap	Sublease Income SubleaseIncome	5200	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	128921	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	85653	shares
CY2024Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	421258	shares
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	dei	Auditor Firm AuditorFirmId	468
CY2024	almu	Sub Lease Rental Income And Other Income SubLeaseRentalIncomeAndOtherIncome		usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2024	almu	Payment For Leasehold Improvements PaymentForLeaseholdImprovements		usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001828805

Files In Submission

Name	View Source	Status
0001213900-24-082694-index-headers.html	Edgar Link	pending
0001213900-24-082694-index.html	Edgar Link	pending
0001213900-24-082694.txt	Edgar Link	pending
0001213900-24-082694-xbrl.zip	Edgar Link	pending
almu-20240630.xsd	Edgar Link	pending
ea0215719-10k_aelumainc.htm	Edgar Link	pending
ea021571901ex31-1_aelumainc.htm	Edgar Link	pending
ea021571901ex31-2_aelumainc.htm	Edgar Link	pending
ea021571901ex32-1_aelumainc.htm	Edgar Link	pending
ea021571901ex32-2_aelumainc.htm	Edgar Link	pending
ea021571901ex97-1_aelumainc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
almu-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0215719-10k_aelumainc_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
almu-20240630_cal.xml	Edgar Link	unprocessable
almu-20240630_def.xml	Edgar Link	unprocessable
almu-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALMU
Aeluma, Inc. Stock $almu

2024 Q3 Form 10-K Financial Statement

#000121390024082694 Filed on September 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALMU Aeluma, Inc. Stock $almu

2024 Q3 Form 10-K Financial Statement

#000121390024082694 Filed on September 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALMU
Aeluma, Inc. Stock $almu